CDKN1B and breast cancer: Our results showed that p27 ability to bind miR-223 paralleled the levels of T157 phosphorylation, with the p27T157D mutant displaying the greatest ability (Figure 6E and F), thus providing an explanation for the positive correlation observed in breast cancers (Figure 6D).